Cargando…
Pathological response and serum VEGF changes during chemoradiotherapy for esophageal carcinoma
The aim of this study was to observe pathological response and change in serum vascular endothelial growth factor (VEGF) in esophageal carcinoma (EC) during chemoradiotherapy (CRT). Eighty-nine patients diagnosed with EC were treated with radiotherapy at the Department of Radiotherapy of the Second...
Autores principales: | Wang, Jian, Yu, Jing-Ping, Ni, Xin-Chu, Sun, Zhi-Qiang, Sun, Wei, Nie, Bin, Sun, Su-Ping, Wang, Jian-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531147/ https://www.ncbi.nlm.nih.gov/pubmed/31096474 http://dx.doi.org/10.1097/MD.0000000000015627 |
Ejemplares similares
-
Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
por: Wang, Dong-Bin, et al.
Publicado: (2016) -
Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers
por: Zhang, Tian-Wei, et al.
Publicado: (2023) -
VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
por: Yoon, Mee Sun, et al.
Publicado: (2011) -
Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer
por: Wang, Xue, et al.
Publicado: (2018) -
CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy
por: Yan, Shuo, et al.
Publicado: (2023)